Grayscale staking launched on 6 October 2025, enabling direct staking for Grayscale’s Ethereum and Solana trusts and offering investors access to on‑chain rewards.
On 6 October 2025 Grayscale activated staking for the Grayscale Ethereum Trust (ETHE) and the Grayscale Solana Trust (GSOL). GSOL is quoted on OTC Markets Group and its uplisting as an ETP remains subject to regulatory approval.
As Grayscale noted in its announcement:
The firm also published the educational report Staking 101: Secure the Blockchain, Earn Rewards to explain mechanics and risks.
Staking is processed at the product level. Trust holdings are routed to a diversified network of validators that earn on‑chain rewards. Consequently, investors gain exposure to staked ether rewards and Solana staking income without running validators themselves.
Retail investors access staking exposure via their brokerage or Grayscale product portals. Institutional flows for GSOL may use OTC counterparties for large trades. For full custody and portal details, see Grayscale’s official disclosures.
Participation follows each product’s investor rules. Minimums and accreditation requirements differ by jurisdiction, so investors must confirm terms with Grayscale or their broker.
Standard KYC/AML checks apply. Also note that ETHE and GSOL are not registered under the Investment Company Act of 1940, which affects distribution and availability in some jurisdictions.
Yield rates vary with network conditions and validator performance. Grayscale passes staking yields to holders net of product fees. Actual returns therefore fluctuate and are described in the product documentation.
A validator network is a set of independent operators that run consensus nodes. Grayscale routes assets to vetted validators to reduce single‑operator risk and to capture block rewards while keeping custody separate from validation. In practice, teams should expect a short reconciliation cycle after activation.
OTC markets supply liquidity for large GSOL positions while staking is active. Yet OTC execution can add counterparty and settlement risk, which investors should weigh against potential yield.
Regulatory shifts can affect uplisting, distribution and tax treatment. Investors face custodial and liquidity risks and should review official disclosures before allocating capital.


